Randomized trial: Imipenem/Cilastatin/Relebactam vs. Piperacillin/Tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia 16 Aug, 2020 | 22:12h | UTC A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study) – Clinical Infectious Diseases